News for Healthier Living

Caris Life Sciences Publishes Study Showing its Multi-Layer AI-Based Tissue of Origin Predictions are Best-in-Class and Identify when Patients have been Misdiagnosed

Caris Life Sciences(r) (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, recently published a study on the development and validation of Caris' latest version of Caris GPSai(tm) in AACR's Cancer Research Communications Journal.

August 5, 2025


August 5 2025

August 4 2025

August 3 2025

August 2 2025

August 1 2025

July 31 2025

July 30 2025

July 29 2025

July 28 2025

July 26 2025

July 25 2025

July 24 2025

July 23 2025